Preoperative transbronchial marking for elevating surgical accuracy in small lung nodules.

Preoperative transbronchial marking using virtual-assisted bronchoscopic navigation for elevating accuracy in surgery for small lung nodules. - ICG-VAL-MAP

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs051180053

Enrollment

200

Registered

2019-02-08

Start date

2017-01-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung tumor Lung cancer

Interventions

Preoperative transbronchial marking is performed using ICG and contarst enghancement agent. Then, markings are confirmed by CT and fluorescence-guided surgery is performed.

Preoperative transbronchial marking

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo surgery in Kyoto University and who is considered to be necessary for preoperative marking.

Exclusion criteria

Exclusion criteria: Patients who are allergic to indocyanine green or contrast enhancement agent, those who are 19 years old or younger, those with cognitive disorders, and those with a history of asthma.

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of marking	—

Secondary

Measure	Time frame
Effect on the surgical outcomes	—

Contacts

Public ContactDaisuke NAKAJIMA

Kyoto University

daink@kuhp.kyoto-u.ac.jp+81-75-751-4975

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026